Arkolith/Insider Trading/IMA/Form 4

Lu Yufang

Chief Medical OfficerImageneBio, Inc. (IMA) · full profile →Form 4 · filed Aug 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 25, 2025Grant(A)6K——6K
Jul 25, 2025Grant(A)5K——5K
Jul 25, 2025Grant(A)38K——38K
Jul 25, 2025Grant(A)27K——27K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-021290) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML